← Back to Clinical Trials
Recruiting NCT07051135

NCT07051135 HablaRÉ: Self-applied Online Training for Correcting Emotional Reasoning Biases in Public Speaking Anxiety.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07051135
Status Recruiting
Phase
Sponsor Universitat Jaume I
Condition Public Speaking Anxiety
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-05-01
Primary Completion 2025-07

Trial Parameters

Condition Public Speaking Anxiety
Sponsor Universitat Jaume I
Study Type INTERVENTIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-05-01
Completion 2025-07
Interventions
"HablaRÉ": Emotional Reasoning bias correction training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The project aims to assess the feasibility of self-administered training for individuals with public speaking anxiety, specifically targeting the reduction of emotional reasoning bias. It seeks to evaluate the interventions' usability, acceptability, satisfaction and adherence/compliance rates. In addition, the study intends to determine the feasibility of conducting a potential randomised clinical trial to evaluate the true impact of the intervention on emotional reasoning biases and public speaking anxiety levels.

Eligibility Criteria

Inclusion Criteria: 1. Be of legal age. 2. Accept the informed consent. 3. Adequately understand/read Spanish. 4. Have access to a mobile device or computer with an Internet connection. 5. Not receiving any other psychological treatment for public speaking anxiety during the study period. 6. Have a score of 43 or higher on the Emotional reasoning scale (ERPSAS) AND/OR a score of 55 or higher on the Spanish version of the Public Speaking Anxiety Scale (PSAS-S) for fear of public speaking. 7. If taking prescribed medication for anxiety/depression, have had no changes in dosage for at least one month before the procedure. Exclusion Criteria: 1. Not accepting the informed consent. 2. Being a minor. 3. Having a severe mental disorder (bipolar disorder, schizophrenia, or other psychotic disorders) or substance abuse (alcohol or other substances) or having active suicidal plans (suicide item in the ODSIS depression questionnaire ≥ 2) that would prevent participation in the program. 4. In the

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology